Responses of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiac Troponin I (cTnI) to Competitive Endurance Exercise in Recreational Athletes

Abstract

The present study was designed to investigate whether the stress of a half-marathon race can induce myocardial cell injury or left ventricular dysfunction in moderately trained runners of both gender, as assessed by post-race plasma concentrations of biochemical cardiac-specific markers and by quantitative echocardiographic measurements. We examined 12 male (mean ± SD); age: 42.8 ± 7.3 yr; height: 177.6 ± 7.4 cm; body mass: 75.6 ± 9.4 kg; BMI: 24.1 ± 1.8 and 13 female (mean ± SD); age: 39.0 ± 6.5 yr; height: 164.6 ± 6.2 cm; body mass: 58.4 ± 9.8 kg; BMI: 21.5 ± 3.4 recreational runners, who completed a half-marathon race. Blood samples were collected from each subject before the half-marathon race as well as 20 min and 2 h post-race and cardiac troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) were measured. Quantitative echocardiographic analyses of wall dimensions and ejection fraction were also obtained from 14 of 25 subjects within 1 wk after the race. Both blood markers showed significant changes (p < 0.05 - 0.001) over the time course of the three blood draws. A significant percentage of laboratory analytes analyzed in this study were outside the reference ranges and fulfilled conventional criteria for cardiac muscle damage. However, echocardiography within one week following the competition did not show any evidence that running a half-marathon competition damages the myocardium. Strenuous endurance exercise in middle-aged recreational runners induces a significant elevation of biochemical cardiac-specific markers, which may reflect transient subclinical myocardial damage, but can also reflect a physiological reparative or adaptive process.

Key words

Cardiac troponin I - brain natriuretic peptide - echocardiography - myocardial damage - half-marathon running - exercise

References

• 1 ACC/AHA guideline for the clinical application of echocardiography: Executive summary. Executive summary. A report of the American College of Cardiology/American Heart Association. Task force on practice guidelines (Committee on clinical Application of Echocardiography).  J Am Coll Cardiol. 1997;  29 862-879
• 2 Albert C M, Mittleman M A, Chae C U, Lee I M, Hennekens C H, Manson J E. Triggering of sudden death from cardiac causes by vigorous exertion.  N Engl J Med. 2000;  343 1355-1361
• 3 Apple F S, Murakami M M, Jesse R L, Levitt M A, Berger A K, Pearce L A, Collinson P. Near-bedside whole-blood cardiac troponin I assay for risk assessment of patients with acute coronary syndromes.  Clin Chem. 2002;  48 1784-1787
• 4 Barletta G, Stefani L, Del Bene R, Fronzaroli C, Vecchiarino S, Lazzeri C, Fantini F, La Villa G. Effects of exercise on natriuretic peptides and cardiac function in man.  Int J Cardiol. 1998;  65 217-225
• 5 Bartek J, Stejskal D, Lacnak B, Jurakova R. Application of determined NT-proBNP in physical standardized exercise.  Biomed Papers. 2003;  147 71-75
• 6 Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, Trawinski J, Boesgaard S, Aldershvile J. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.  Heart. 2003;  89 150-154
• 7 Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.  Circulation. 2002;  105 2392-2397
• 8 Bertrand M E, Simoons M L, Fox K A, Wallentin L C, Hamm C W, McFadden E, De Feyter P J, Specchia F, Ruzyllo W. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.  Eur Heart J. 2000;  21 1406-1432
• 9 Bonetti A, Tirelli F, Albertini R, Monica C, Monica M, Tredici G. Serum cardiac troponin T after repeated endurance exercise events.  Int J Sports Med. 1996;  17 259-262
• 11 Chen Y, Serfass R C, Mackey-Bojack S M, Kelly K L, Titus J L, Apple F S. Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise.  J Appl Physiol. 2000;  88 1749-1755
• 12 Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review.  Clin Chem. 2004;  50 33-50
• 13 Cleave P, Boswell T C, Speedy D B, Boswell D R. Plasma cardiac troponin concentrations after extreme exercise.  Clin Chem. 2001;  47 608-610
• 14 Cowie M R, Struthers A D, Wood D A, Coats A J, Thompson S G, Poole-Wilson P A, Sutton G C. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.  Lancet. 1997;  350 1349-1353
• 15 Davies E, Gawad Y, Takahashi M, Shi Q, Lam P, Styba G, Lau A, Heeschen C, Usategui M, Jackowski G. Analytical performance and clinical utility of a sensitive immunoassay for determination of human cardiac troponin I.  Clin Biochem. 1997;  30 479-490
• 16 De Lemos J A, Mc Guire D K, Drazner M H. B-type natriuretic peptide in cardiovascular disease.  Lancet. 2003;  362 316-322
• 17 Herrmann M, Scharhag J, Micica M, Urhausen A, Herrmann W, Kindermann W. Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners.  Clinical Chemistry. 2003;  43 209-213
• 18 Huang W S, Lee M S, Perng H W, Yang S P, Kuo S W, Chang H D. Circulating Brain natriuretic peptide values in healthy men before and after exercise.  Metabolism. 2002;  51 1423-1426
• 19 Hunt P J, Richards A M, Nicholls M G, Yandle T G, Doughty R N, Espiner E A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.  Clin Endocrinol. 1997;  47 287-296
• 20 Jensen K T, Carstens J, Ivarsen P, Pedersen E B. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and patients with different diseases.  Scand J Clin Lab Invest. 1997;  57 529-540
• 21 Koller A. Exercise-induced increases in cardiac troponins and prothrombotic markers.  Med Sci Sports Exerc. 2003;  35 444-448
• 22 Koller A, Summer P, Moser H. Regular exercise and subclinical myocardial injury during prolonged aerobic exercise (letter).  JAMA. 1999;  282 1816
• 23 König D, Schumacher Y O, Heinrich L, Schmid A, Berg A, Dickhuth H H. Myocardial stress after competitive exercise in professional road cyclists.  Med Sci Sports Exerc. 2003;  35 1679-1683
• 24 La Gerche A, Boyle A, Wilson A M, Prior D L. No evidence of sustained myocardial injury following an Ironman distance triathlon.  Int J Sports Med. 2004;  25 45-49
• 25 Laslett L, Eisenbud E, Lind R. Evidence of myocardial injury during prolonged strenuous exercise.  Am J Cardiol. 1996;  78 488-490
• 26 Laslett L, Eisenbud E. Lack of detection of myocardial injury during competitive races of 100 miles lasting 18 to 30 hours.  Am J Cardiol. 1997;  80 379-380
• 27 Loke I, Squire I B, Davies J E, Ng L L. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.  Eur J Heart Fail. 2003;  5 599-606
• 28 Lucia A, Serratosa L, Saborido A, Pardo J, Boraita A, Moran M, Bandres F, Megias A, Chicharro J. Short-term effects of marathon running: no evidence of cardiac dysfunction.  Med Sci Sports Exerc. 1999;  31 1414-1421
• 29 Mair J, Schobersberger W, Koller A, Bialk P, Villiger B, Frey W, Puschendorfer B. Risk for exercise-induced myocardial injury for athletes performing prolonged strenuous endurance exercise (Letter).  Am J Cardiol. 1997;  80 543-544
• 30 Maron B J, Thompson P D, Puffer J C, McGrew C A, Strong W B, Douglas P S, Clark L T, Mitten M J, Crawford M H, Atkins C L, Driscoll D J, Epstein A E. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association.  Circulation. 1996;  94 850-856
• 31 McDonagh T A, Robb S, Murdoch D R, Morton J J, Ford I, Morrison C E, Tunstall-Pedoe H, McMurray J J, Dargie H J. Biochemical detection of left-ventricular systolic dysfunction.  Lancet. 1998;  351 9-13
• 32 McLean A S, Huang S J, Nalos M, Tang B, Stewart D E. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients.  Crit Care Med. 2003;  31 2611-2618
• 33 McNairy M, Gardetto N, Clopton P, Garcia A, Krishnaswamy P, Kazanegra R, Ziegler M, Maisel A S. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide.  Am Heart J. 2002;  143 406-411
• 34 Mittleman M A, Maclure M, Tofler G H, Sherwood J B, Goldberg R J, Muller J E. Triggering of acute myocardial infarction by heavy physical exertion.  N Engl J Med. 1993;  329 1677-1683
• 35 Nadal-Ginard B, Kajstura J, Anversa P, Leri A. A matter of life and death: cardiac myocyte apoptosis and regeneration.  J Clin Invest. 2003;  111 1457-1459
• 36 Neumayr G, Gaenzer H, Pfister R, Sturm W, Schwarzacher S P, Eibl G, Mitterbauer G, Hoertnagl H. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise.  Am J Cardiol. 2001;  87 369-371
• 37 Niessner A, Ziegler S, Slany J, Billensteiner E, Woloszczuk W, Geyer G. Increases in plasma levels of atrial and brain natriuretic peptides after running a marathon: are their effects partly counterbalanced by adrenocortical steroids?.  Eur J Endocrinol. 2003;  149 555-559
• 38 Ohba H, Takada H, Musha H, Nagashima J, Mori N, Awaya T, Omiya K, Murayama M. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.  Am Heart J. 2001;  141 751-758
• 39 Ottani F, Galvani M, Nicolini F A, Ferrini D, Pozzati A, Di Pasquale G, Jaffe A S. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes.  Am Heart J. 2000;  140 917-927
• 40 Redfield M M, Rodeheffer R J, Jacobsen S J, Mahoney D W, Bailey K R, Burnett Jr J C. Plasma brain natriuretic peptide concentration: impact of age and gender.  J Am Coll Cardiol. 2002;  40 976-982
• 41 Rifai N, Douglas P S, O'Toole M, Rimm E, Ginsburg G S. Cardiac troponin T and I, echocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon.  Am J Cardiol. 1999;  83 1085-1089
• 42 Shave R, Dawson E, Whyte G, George K, Ball D, Collinson P, Gaze D. The cardiospecificity of the third-generation cTnT assay after exercise-induced muscle damage.  Med Sci Sports Exerc. 2002;  34 651-654
• 43 Siegel A J, Lewandrowski E L, Chun K Y, Sholar M B, Fischman A J, Lewandrowski K B. Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon.  Am J Cardiol. 2001;  88 920-923
• 44 Steele I C, McDowell G, Moore A, Campbell N P, Shaw C, Buchanan K D, Nicholls D P. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects.  Eur J Clin Invest. 1997;  27 270-276
• 45 Stein B C, Levin R I. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.  Am Heart J. 1998;  135 914-923
• 46 Tanabe K, Yamamoto A, Suzuki N, Akashi Y, Seki A, Samejima H, Oya M, Murabayashi T, Nakayama M, Yokoyama Y, Osada N, Omiya K, Itoh H, Miyake F, Murayama M. Exercise-induced changes in plasma atrial natriuretic peptide and brain natriuretic peptide concentration in healthy subjects with chronic sleep deprivation.  Jpn Circ J. 1999;  63 447-452
• 47 Willich S N, Lewis M, Lowel H, Arntz H R, Schubert F, Schroder R. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group.  N Engl J Med. 1993;  329 1684-1690
• 48 Yamazaki H, Senju Y, Kinoshita N, Katsukawa F, Onishi S. Plasma brain natriuretic peptide in athletes.  Am J Cardiol. 2000;  85 1393-1394